Bone is a type of connective tissue composed of two parts: organic (cells and collagen fibers) and mineral (calcium and phosphate compounds). The main mineral components in bones are apatites1. Different types of mineralization-competent cells in bone (osteoblasts), in teeth (odontoblasts) and in cartilage (chondrocytes) regulate the initial steps of mineralization by producing proteins of the extracellular matrix (ECM) and releasing matrix vesicles (MVs) (Figure 1). MVs are 100-300 nm diameter vesicles that accumulate calcium and phosphate facilitating apatite nucleation and subsequently bind to collagen2,3. Then, MVs disintegrate to release apatites to the extracellular medium. The apatites continue to grow in contact with collagen fibers and form the bone matrix. The mineralization is sustained by the constant supply of Pi and Ca2+ in the extracellular medium. Some recently published data support our model4,5. Soft tissues do not mineralize under physiological conditions. However, ectopic calcification may occur under pathological conditions such as vascular calcification3. Vascular cells that acquire the osteoblast phenotype can produce MVs that induce nucleation of apatites and initiate mineralization in the medial and intimal layers of the wall of blood vessels. Since ectopic calcification resemble normal endochondral mineralization3, understanding the molecular mechanisms of mineralization of osseous cells and chondrocytes should provide some clues on ectopic calcification of soft tissues that are formed.
The development of skeletal tissues is regulated by various enzymes, growth factors, and promoters or inhibitors of mineralization. The antagonistic action of tissue-nonspecific alkaline phosphatase (TNAP) (Figure 1) and ectonucleotide pyrophosphatase/phosphodiesterase I (NPP1), together with ankyrin (ANK), controls inorganic pyrophosphate (PPi) concentration6. PPi, a potent inhibitor of HA formation, is hydrolyzed by TNAP; NPP1 hydrolyzes nucleotide triphosphates to form PPi while ANK exports PPi from the cell to the ECM. The Pi/PPi ratio may regulate apatite formation7,8 with possible pathological consequences9.
The MV membrane is enriched in ion transport proteins that facilitate the initial precipitation of calcium and phosphate inside the MVs during the nucleation process (Figure 1). The phosphate transporter 1 (PiT) helps to incorporate Pi generated in the perivesicular space into the MVs10,11. Annexins may be involved in the binding and transport of Ca2+ and in the biophysical process that initiates mineralization in the MV lumen12,13. We favor the hypothesis, suggested earlier, for mineralization within intracytoplasmic vesicles of internal nucleation of apatite inside the MV before its propagation in the ECM14,15. In vitro modeling confirmed the induction of Ca2+/Pi complexes formation in proteoliposomes made from PS and AnxA516. This may indicate that accumulation of Ca2+, Pi, AnxA5 and PS complexes in lipid rafts of microvilli-like membranesrepresent the nucleation core (NC) of apatite within MVs. Annexins and TNAP also possess collagen-binding capacities that may be helpful in placing MVs along collagen fibers and, in stimulating the propagation of mineralization in the ECM. Fetuin A and osteopontin (OPN)17, are known as inhibitors of apatite formation that may slow down the propagation of mineralization on the collagenous scaffold. Nucleation and propagation are distinct events, the former preceding the latter, and both may be relevant for the process of pathological mineralization.
To discover how the chemistry of calcium phosphate complexes may change physiological mineralization and ectopic calcification, it is necessary to identify the minerals produced by cells. Apatites are a group of calcium and phosphate containing minerals with the general crystal unit cell formula Ca10(PO4)6X2, where X = Cl, F, OH. They are classified as follows18: fluorapatite (FA) Ca10(PO4)6F2, chlorapatite (CA) Ca10(PO4)6Cl2 and hydroxyapatite (HA) Ca10(PO4)6(OH)2.
The choice of osteoblast cell lines to induce mineral formation is crucial, since each cell line exhibits a distinct profile of mineralization. In this report, we compared the nucleation of minerals by two selected human cell models of mineralization: osteoblastic hFOB 1.19 cells and osteosarcoma Saos-2 cells. Osteosarcoma-derived cells are commonly used as osteoblastic models and Saos-2 cells have preserved the most mature osteoblastic character19 while undifferentiated human fetal hFOB cells are widely used as a model for normal osteoblastic differentiation20. Their mineralization profiles were analyzed by different methods: Alizarin Red-S (AR-S) staining, ultraviolet (UV) light visualization, transmission electron microscopy (TEM) imaging, energy dispersive X-ray microanalysis (EDX) quantitation, and ion mapping. The advantage of TEM-EDX over alternative techniques used in previous studies is that it gives quantitative and qualitative results of ion replacement in apatite crystals4,5,21. The overall goal of using TEM-EDX was to find a simple method for imaging and quantification of the distribution of Ca, F and Cl ions in various minerals from different types of cells during distinct stages of the mineralization process. This method has been successfully used, for example, for monitoring the interaction of zinc nanoparticles with coexisting chemicals and their combined effects on aquatic organisms22. In another study, a copper photocatalyst on titanium materials in aqueous solution was extensively characterized by means of inductively coupled plasma optical emission spectrometry (ICP-OES), N2 physisorption (BET), XRD, UV-vis DRS, FT-IR, Raman spectroscopy, TEM-EDX, and photoelectrochemical measurements23. Our aim was to compare the origin and properties of vesicles and minerals in two cell lines to understand the mechanism that controls mineralization during osseous differentiation.

Figure 1. Scheme of the initial steps of mineralization in osseous cells involving the synthesis of extracellular matrix (ECM) proteins and release of matrix vesicles (MVs) from the membrane. MVs accumulate calcium through the action of calcium binding proteins, annexins and phosphate, through the action of an inorganic phosphate transporter (PiT) followed by the activity of tissue non-specific alkaline phosphatase (TNAP), which dephosphorylates PPi to Pi, thereby facilitating apatite nucleation. Then, MVs disintegrate and release apatites to the extracellular medium. The mineralization is sustained by the constant supply of Pi and Ca2+ in the extracellular medium4,5. Please click here to view a larger version of this figure.